Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › ID › Idaho Falls › NPI 1225082209
Hospital

Eastern Idaho Health Services INC

Eastern Idaho Health Services INC was paid $12.15M by Medicaid between Jan 2018 and Dec 2024, across 223 billing codes. Its largest line is 99284, emergency room visit (serious) — 30% of everything it billed.

33Billing provider infoEASTERN IDAHO HEALTH SERVICES INC
IDAHO FALLS, ID 83404
33aNPI1225082209assigned 05/22/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$12.15M
24GClaims374,425
24DCodes billed223
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Idaho

Rank by total paid#1 of 12
Median peer was paid$3.12M
This provider vs. median3.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018144,202$4.33M
2019133,556$4.97M
202067,527$2.66M
20218,009$66K
20228,531$78K
20237,274$29K
2024incomplete5,326$22K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 30% 17,796 14,831 $3.68M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 25% 17,980 16,175 $3.03M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.9% 2,030 1,816 $592K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 3.2% 1,063 1,013 $391K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.8% 14,521 11,706 $341K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.7% 4,148 3,940 $332K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.1% 2,254 2,041 $258K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.8% 7,943 6,568 $222K
96375 Therapeutic injection; each additional sequential IV push 1.7% 6,623 5,398 $210K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.6% 3,261 966 $194K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.3% 2,250 1,982 $152K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 1.2% 3,077 980 $152K
211 more codes
80053 Comprehensive metabolic panel 1.2% 22,410 $149K
87631 1.2% 1,069 $145K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,543 $110K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,126 $108K
85027 <1% 25,231 $103K
70450 Computed tomography, head or brain; without contrast material <1% 2,622 $90K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 2,946 $90K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,157 $86K
71046 Radiologic examination, chest; 2 views <1% 5,825 $72K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 2,075 $71K
36415 Collection of venous blood by venipuncture <1% 27,275 $67K
87581 <1% 1,968 $63K
87486 <1% 1,965 $63K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 118 $56K
71275 Computed tomographic angiography, chest, with contrast material <1% 586 $53K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 884 $47K
84443 Thyroid stimulating hormone (TSH) <1% 3,297 $43K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 716 $42K
87088 <1% 6,148 $41K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,996 $41K
86140 <1% 11,157 $41K
81001 <1% 16,278 $39K
84703 <1% 5,551 $36K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 95 $35K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 1,147 $31K
87507 <1% 100 $31K
72125 Computed tomography, cervical spine; without contrast material <1% 560 $28K
12001 <1% 362 $27K
90870 <1% 197 $24K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 640 $20K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 640 $20K
84439 <1% 2,755 $20K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 3,873 $20K
84484 <1% 4,402 $19K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,656 $19K
83690 <1% 4,143 $19K
12011 <1% 216 $18K
Q4133 Grafix prime, grafixpl prime, stravix and stravixpl, per square centimeter (add-on, list separately in addition to primary procedure) <1% 29 $18K
74018 <1% 1,324 $17K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 129 $17K
J7030 Infusion, normal saline solution , 1000 cc <1% 12,010 $16K
71045 Radiologic examination, chest; single view <1% 4,035 $15K
87040 <1% 1,835 $14K
84112 <1% 189 $14K
87081 <1% 2,041 $13K
93971 <1% 321 $13K
87077 <1% 2,039 $13K
80048 Basic metabolic panel (calcium, ionized) <1% 2,412 $12K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 263 $12K
87186 <1% 1,803 $12K
J3486 Injection, ziprasidone mesylate, 10 mg <1% 688 $11K
83880 <1% 811 $11K
97163 <1% 292 $10K
84702 <1% 698 $10K
73130 <1% 579 $10K
73610 <1% 658 $10K
85379 <1% 1,283 $9K
80061 Lipid panel <1% 769 $9K
82550 <1% 2,265 $9K
87505 <1% 76 $9K
83605 <1% 1,343 $9K
99213 Doctor's office visit, returning patient (routine) <1% 462 $9K
73630 <1% 637 $8K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 165 $8K
96361 Intravenous infusion, hydration; each additional hour <1% 392 $8K
83735 <1% 2,994 $8K
82553 <1% 1,385 $7K
36000 <1% 877 $7K
99152 <1% 98 $7K
70486 <1% 110 $7K
87660 <1% 334 $6K
72100 <1% 560 $6K
73110 <1% 380 $6K
76801 <1% 129 $6K
76770 <1% 122 $6K
87480 <1% 334 $6K
87510 <1% 334 $6K
99153 Mod sedat endo service >5yrs <1% 57 $6K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,083 $6K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 143 $5K
70551 Magnetic resonance imaging, brain; without contrast material <1% 69 $5K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 90 $5K
88304 <1% 196 $5K
73030 <1% 461 $5K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 138 $5K
87070 <1% 753 $5K
73562 <1% 311 $5K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 60 $5K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 37 $5K
82248 <1% 1,218 $4K
90715 <1% 238 $4K
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,520 $4K
72040 <1% 358 $4K
87205 <1% 1,248 $4K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 314 $4K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,979 $4K
85610 <1% 1,661 $4K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 96 $4K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 579 $3K
85730 <1% 868 $3K
77067 Screening mammography, bilateral, including computer-aided detection <1% 106 $3K
G0378 Hospital observation service, per hour <1% 803 $3K
99214 Doctor's office visit, returning patient (more involved) <1% 249 $3K
J2550 Injection, promethazine hcl, up to 50 mg <1% 1,767 $3K
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 770 $3K
86850 <1% 611 $3K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,783 $3K
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care <1% 481 $3K
29125 <1% 61 $3K
73090 <1% 188 $2K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 15 $2K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 689 $2K
85651 <1% 850 $2K
84145 <1% 153 $2K
J7060 5% dextrose/water (500 ml = 1 unit) <1% 1,543 $2K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 2,741 $2K
83036 Hemoglobin; glycosylated (A1C) <1% 314 $2K
87335 <1% 191 $2K
86900 <1% 749 $2K
87493 <1% 79 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 6,858 $2K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,287 $2K
76830 Ultrasound, transvaginal <1% 26 $2K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 15 $2K
86901 <1% 750 $2K
82728 <1% 168 $2K
87045 <1% 191 $2K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,594 $1K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 72 $1K
87075 <1% 220 $1K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 43 $1K
59025 Fetal non-stress test <1% 96 $1K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,905 $1K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 113 $1K
73590 <1% 116 $1K
73140 <1% 74 $1K
82784 <1% 116 $1K
16020 <1% 17 $1K
74021 <1% 81 $1K
88300 <1% 100 $1K
73560 <1% 75 $1K
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 383 $1K
12002 <1% 14 $910.50
87329 <1% 77 $787.39
72131 <1% 14 $771.05
83550 <1% 120 $723.32
J1644 Injection, heparin sodium, per 1000 units <1% 420 $710.19
80203 <1% 50 $705.08
J7050 Infusion, normal saline solution, 250 cc <1% 1,172 $701.39
73502 <1% 46 $637.59
83540 <1% 132 $628.61
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,023 $612.14
83516 <1% 59 $609.27
J0690 Injection, cefazolin sodium, 500 mg <1% 459 $575.94
74019 <1% 44 $566.38
89055 <1% 153 $537.49
J2060 Injection, lorazepam, 2 mg <1% 980 $499.65
73080 <1% 27 $427.34
82140 <1% 50 $368.37
97116 <1% 29 $365.92
87328 <1% 40 $345.18
84100 <1% 150 $325.10
82270 <1% 102 $322.19
71101 <1% 26 $291.84
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 2,120 $283.92
J8540 Dexamethasone, oral, 0.25 mg <1% 90 $253.12
82247 <1% 45 $250.65
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,066 $243.12
86308 <1% 44 $242.80
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 221 $223.74
J3360 Injection, diazepam, up to 5 mg <1% 66 $207.90
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 569 $205.05
89051 <1% 53 $189.72
73552 <1% 13 $184.34
J2704 Injection, propofol, 10 mg <1% 469 $180.73
J1170 Injection, hydromorphone, up to 4 mg <1% 115 $173.20
82150 <1% 40 $164.73
97035 <1% 34 $154.06
84157 <1% 28 $147.67
96376 <1% 1,637 $147.56
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 4,045 $131.55
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 18 $123.84
82607 <1% 14 $117.25
0100U <1% 630 $109.34
86038 <1% 12 $108.24
81002 <1% 37 $95.89
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 126 $92.39
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 852 $92.12
82570 <1% 24 $92.00
82009 <1% 30 $89.21
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 122 $83.75
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 13 $78.56
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 140 $76.50
80069 <1% 18 $67.55
C1769 Guide wire <1% 191 $64.95
G0383 Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 779 $39.07
76937 <1% 18 $34.38
84156 <1% 12 $24.48
J7510 Prednisolone oral, per 5 mg <1% 40 $12.60
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 68 $2.71
Q0169 Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 13 $0.94
77063 Screening digital breast tomosynthesis, bilateral 0% 78 $0.00
A9270 Non-covered item or service 0% 4,112 $0.00
0098U 0% 651 $0.00
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 0% 69 $0.00
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 0% 17 $0.00
J7999 Compounded drug, not otherwise classified 0% 14 $0.00
G0381 Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) 0% 537 $0.00
G0380 Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) 0% 118 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 15 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMARTIN, AARON (CFO)